|
US9193681B1
|
|
Propionic acids, propionic acid esters, and related compounds
|
|
EP3066089A1
|
|
Substituted n-acetyl-l-cysteine derivatives and related compounds
|
|
US2015045312A1
|
|
Use of Compounds Elevating Glutathione Levels for the Treatment of Autism, Autistic Spectrum Disorders and Fragile X Syndrome
|
|
US2013338165A1
|
|
Use of Compounds Elevating Glutathione Levels for the Treatment of Parkinson's Disease
|
|
EP2736890A1
|
|
Cysteine prodrugs
|
|
WO2012065110A2
|
|
S-protected cysteine analogs and related compounds
|
|
EP2638005A2
|
|
S-t-butyl protected cysteine di-peptide analogs and related compounds
|
|
CA2792598A1
|
|
Improved cysteine-based prodrugs useful in the treatment of schizophrenia
|
